Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 114, Issue 9, Pages 1272-1280Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI200421022
Keywords
-
Categories
Funding
- Intramural NIH HHS [Z01 DK056008] Funding Source: Medline
- NCI NIH HHS [CA-68485, P30 CA068485] Funding Source: Medline
- NIDDK NIH HHS [DK-56008, P30 DK058404, DK-58404, R01 DK056008] Funding Source: Medline
Ask authors/readers for more resources
TNF plays a pathogenic role in inflammatory bowel diseases (IBDs), which are characterized by altered cytokine production and increased intestinal epithelial cell apoptosis. In vitro studies suggest that kinase suppressor of Ras-1 (KSR1) is an essential regulatory kinase for TNF-stimulated survival pathways in intestinal epithelial cell lines. Here we use a KSR1-deficient mouse model to study the role of KSR1 in regulating intestinal cell fate during cytokine-mediated inflammation. We show that KSR1 and its target signaling pathways are activated in inflamed colon mucosa. Loss of KSR1 increases susceptibility to chronic colitis and TNF-induced apoptosis in the intestinal epithelial cell. Furthermore, disruption of KSR1 expression enhances TNF-induced apoptosis in mouse colon epithelial cells and is associated with a failure to activate antiapoptotic signals including Raf-1/MEK/ERK, NF-kappaB, and Akt/protein kinase B. These effects are reversed by WT, but not kinase-inactive, KSR1. We conclude that KSR1 has an essential protective role in the intestinal epithelial cell during inflammation through activation of cell survival pathways.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available